Drug Utilization and Evaluation of Gestational Diabetes Mellitus
Maheshwari P*, Guna B, Kumar M Ranjith, Renugadevi S
Department of Pharmacy Practice, School of Pharmaceutical Sciences, Vels University (VISTAS) Pallavaram, Chennai-600117, Tamilnadu, India
*Corresponding Author E-mail: email@example.com
Online published on 26 March, 2018.
Aim and Objectives
The aim of the study is to analyse and utilize regarding the gestational diabetes in the prescription given in the Gynaecology department of a tertiary care Hospital. To get an insight into the current pattern of prescriptions in Gestational Diabetes.
Materials and Methods
A Prospective study has been carried out for a period of 6 months(December 2016-April2017) in a Tertiary Care Hospital Tamilnadu Maternity Government Hospital located at Chennai.50 patients were diagnosed with Gestational Diabetes. The case sheets of the patients are thoroughly studied.
Results and Discussion
Total of 50 gestational diabetes patients were studied. Among the study population age was ranging from 20–30 years. The number of patients ranging from 20–30 years were 37 (74%), and the number of patients ranging from 30–40 years were 13 (26%).The Route of Administration in GDM are done by two routes. The oral dosage Form (22%) and another is subcutaneous dosage form (88%).The Trimester of GDM are found among Patients.
According to the survey GDM mainly occurs in the age ranging from 20–30 years and also they are more commonly affected in the Second Trimester (3–6 months) of Pregnancy. Insulin is found to be more safe than compered to oral Hypoglycaemic drugs because the drugs which contain Molecular Weight less than 500 Da crosses the Placental barrier. Insulin molecular weight is greater than 1000 Da, so it do not cross the placenta. The study found that insulin are potent and safe. So, they are prescribed in extensively in GDM.
Drug Utilization, Gestational Diabetes Mellitus (GDM), Hypoglycaemic, Insulin, Placenta.